Navigation Links
Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
Date:10/12/2009

in(TM) be completed prior to regulatory approval. Triapine®, a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion being unsuccessful in achieving its strategic alternatives, including any combination of a restructuring of the Company and its debt, a sale of the Company or its assets, and raising new capital, in which case it may have to consider curtailing or ceasing operations or liquidating its assets, Vion's potential inability to obtain regulatory approval for its products, particularly Onrigin(TM) (laromustine) Injection, delays in the regulatory approval process, particularly for Onrigin(TM) (laromustine) Injection, delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not confirmed by safety and efficacy results in later or final clinical trials, the need for additional research and testing, including the need for a new randomized trial of Onrigin(TM) prior to regulatory approval in accordance with the recommendation of the Oncologic Drug Advisory Committee, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit Breakers announced ... Module. The X3130, integrated with E-T-A,s double-pole ... appliance inlet module, rocker switch and resettable overcurrent ... allows design engineers to streamline the number of ... by 66 percent - and reduce the overall ...
(Date:6/18/2013)... Mass. , June 18, 2013 ... the company was named Overall Performance Leader in Imaging ... Equipment & Infrastructure report. Philips also received Best in ... its imaging products: Ingenuity Core 128 Computed Tomography ... ultrasound and PageWriter TC70 cardiograph. The annual Best in ...
(Date:6/18/2013)... June 18, 2013 Unilife Corporation ("Unilife" or ... developer and manufacturer of injectable drug delivery systems, today ... www.unilife.com . The new site includes additional products, ... occur on a regular basis. Mr. ... an emerging global leader for injectable drug delivery systems, ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Unilife Launches New Corporate Website 2
... 2011  Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE)("Ampio" or the "Company"), ... previously approved drugs and new molecular entities ("NMEs"), announced ... accredited investors to sell an aggregate approximately 2,220,255 of ... share (the "Shares"), at a price per share of ...
... Radiologic (vRad), a technology-enabled national radiology practice, ... Montgomery Radiology Associates (MRA) have joined its ... Inc. (DII). These former MRA radiologists will ... (PMMC) and join the more than 60 ...
Cached Medicine Technology:Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 2Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 3vRad Radiology Alliance Continues to Transform Radiology With Most Recent Practice Partnership 2
(Date:6/19/2013)... Pass, OR (PRWEB) June 19, 2013 To survive ... Navy Pilot and Vietnam veteran Captain W.S. “Bud” Orr, the most ... water. Speaking to host Sharon Kleyne on the Sharon Kleyne Hour ... survival kit in Vietnam, he always placed extra water ahead of ... a weight limit on survival kits that pilots could carry on ...
(Date:6/19/2013)... McGuff Pharmaceuticals, Inc. continues to ... (ANDA) for Hydroxyprogesterone Caproate Injection, USP 250mg/mL, 5mL, multiple ... fomerly known as Delalutin™. We are providing this ... approval and market introduction dates for McGuff’s Hydroxyprogesterone Caproate ... our pending ANDA, to date, McGuff has responded to ...
(Date:6/19/2013)... Calculating insurance rates is a complex process that requires insurance ... course their own company policies. This process is a ... to company, and why by shopping around for the ... as car insurance can be a hefty expense for all ... factors that determine their car insurance premiums. These tips ...
(Date:6/19/2013)... Sudden cardiac arrest can strike anyone, even a ... of 5 minutes after cardiac arrest, but the average emergency ... that death is highly probable if an automated external defibrillator ... In response to this dire reality, US Representative Lois Capps ... (H.R. 2308) which would provide support for AED and CPR ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Anant Goel, CEO ... and changing rapidly. The first industrial revolution began in Britain ... textile industry… when the factory was born. The second industrial ... mastered the moving assembly line and ushered in the age ... in the 21st century. Manufacturing is going digital and this ...
Breaking Medicine News(10 mins):Health News:Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit 2Health News:Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP 2Health News:icandrive.ca Provides Tips to Understand the Top Factors That Affect Car Insurance Premiums 2Health News:icandrive.ca Provides Tips to Understand the Top Factors That Affect Car Insurance Premiums 3Health News:AED.com Supports Automated External Defibrillator (AED) Legislation in Schools in US and UK 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 3Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 4
... ... the parts washing industry. Midbrook has extensive experience washing parts and equipment in a variety ... facility to help a North American automotive parts supplier solve a de-rusting issue. , ... (Vocus) October 6, 2009 -- ...
... Michael Pernecky ... ... of access control and photo ID products, today announced the promotion of Michael Pernecky to ... card line as well as working hand in hand with our sales staff in developing ...
... 6 The authors of a newly published ... conclude that the micro-bland embolization technique possible with ... Franco Orsi, MD, PhD, and colleagues at the ... that small, tightly calibrated Embozene(TM) Microspheres are better ...
... HOSPITAL ROOM , New research shows that certain noninvasive ... up to a distance of 1 m from patients ... spread of highly contagious respiratory illness within the hospital ... with mild lung injury, researchers from Hong Kong measured ...
... In response to recent research that shows young athletes ... future neurological problems, the Illinois Athletic Trainers Association (IATA) ... are offering a wallet-sized card with tips for detecting ... parents, coaches and others who work with young athletes ...
... MOORESVILLE, N.C., Oct. 5 With medical identity theft ... has chosen to implement Palm Identify, a software application ... purpose of the new solution is to enhance patient ... , Hugh Chatham Memorial Hospital is a private, not-for-profit ...
Cached Medicine News:Health News:Midbrook Production Washing A Valuable Partner 2Health News:Midbrook Production Washing A Valuable Partner 3Health News:Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres 2Health News:News briefs from the October issue of Chest 2Health News:New Complimentary Wallet Card to Tackle Concussions 'Head On' 2Health News:Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: